Adventitial expression of recombinant eNOS gene restores NO production in arteries without endothelium

Masato Tsutsui, Alex F Y Chen, Timothy O'Brien, Thomas B. Crotty, Zvonimir S Katusic

Research output: Contribution to journalArticle

49 Citations (Scopus)

Abstract

The current study was designed to determine the effect of recombinant endothelial nitric oxide synthase (eNOS) gene expression on endothelium- dependent relaxations to bradykinin in isolated canine basilar, coronary, or femoral arteries. Arterial rings were exposed ex vivo (30 minutes at 37°C) to an adenoviral vector encoding either the eNOS gene (AdCMVeNOS) or the β- galactosidase reporter gene (AdCMVβ-Gal). Twenty-four hours after transduction, transgene expression was evident mainly in the adventitia. Expression of recombinant proteins was much higher in basilar arteries than in coronary or femoral arteries. Rings of control, AdCMVβ-Gal, and AdCMVeNOS arteries with and without endothelium were suspended for isometric tension recording. Levels of cGMP were measured by radioimmunoassay. In AdCMVeNOS basilar arteries with endothelium, relaxations to low concentrations of bradykinin (3 x 10-11 to 10-9 mol/L) were significantly augmented. In contrast, in coronary and femoral arteries with endothelium, AdCMVeNOS transduction did not affect relaxations to bradykinin. Removal of the endothelium abolished bradykinin-induced relaxations in control and AdCMVβ- Gal basilar arteries. However, in basilar arteries transduced with AdCMVeNOS even when the endothelium was removed, stimulation with bradykinin (3 x 10- 11 to 10-9 mol/L) caused relaxations as well as increases in cGMP production. The relaxations to bradykinin were completely blocked by an NOS inhibitor, N(G)-nitro-L-arginine methyl ester. Electron microscopic analysis revealed that recombinant eNOS protein was expressed in fibroblasts of the basilar artery adventitia. These results suggest that genetically modified adventitial fibroblasts may restore production of NO in cerebral arteries without endothelium. Our findings support a novel concept in vascular biology that fibroblasts in the adventitia may play a role in the regulation of vascular tone after successful transfer and expression of recombinant eNOS gene.

Original languageEnglish (US)
Pages (from-to)1231-1241
Number of pages11
JournalArteriosclerosis, Thrombosis, and Vascular Biology
Volume18
Issue number8
StatePublished - 1998

Fingerprint

Adventitia
Nitric Oxide Synthase Type III
Basilar Artery
Bradykinin
Endothelium
Arteries
Genes
Femoral Artery
Galactosidases
Coronary Vessels
Fibroblasts
Reporter Genes
Blood Vessels
Cerebral Arteries
NG-Nitroarginine Methyl Ester
Transgenes
Recombinant Proteins
Radioimmunoassay
Canidae
Electrons

Keywords

  • Adenoviral vector
  • Bradykinin
  • Fibroblasts
  • Gene therapy
  • Gene transfer

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Adventitial expression of recombinant eNOS gene restores NO production in arteries without endothelium. / Tsutsui, Masato; Chen, Alex F Y; O'Brien, Timothy; Crotty, Thomas B.; Katusic, Zvonimir S.

In: Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 18, No. 8, 1998, p. 1231-1241.

Research output: Contribution to journalArticle

Tsutsui, Masato ; Chen, Alex F Y ; O'Brien, Timothy ; Crotty, Thomas B. ; Katusic, Zvonimir S. / Adventitial expression of recombinant eNOS gene restores NO production in arteries without endothelium. In: Arteriosclerosis, Thrombosis, and Vascular Biology. 1998 ; Vol. 18, No. 8. pp. 1231-1241.
@article{a836d5dd1e934ad6ad729c7ce528be0d,
title = "Adventitial expression of recombinant eNOS gene restores NO production in arteries without endothelium",
abstract = "The current study was designed to determine the effect of recombinant endothelial nitric oxide synthase (eNOS) gene expression on endothelium- dependent relaxations to bradykinin in isolated canine basilar, coronary, or femoral arteries. Arterial rings were exposed ex vivo (30 minutes at 37°C) to an adenoviral vector encoding either the eNOS gene (AdCMVeNOS) or the β- galactosidase reporter gene (AdCMVβ-Gal). Twenty-four hours after transduction, transgene expression was evident mainly in the adventitia. Expression of recombinant proteins was much higher in basilar arteries than in coronary or femoral arteries. Rings of control, AdCMVβ-Gal, and AdCMVeNOS arteries with and without endothelium were suspended for isometric tension recording. Levels of cGMP were measured by radioimmunoassay. In AdCMVeNOS basilar arteries with endothelium, relaxations to low concentrations of bradykinin (3 x 10-11 to 10-9 mol/L) were significantly augmented. In contrast, in coronary and femoral arteries with endothelium, AdCMVeNOS transduction did not affect relaxations to bradykinin. Removal of the endothelium abolished bradykinin-induced relaxations in control and AdCMVβ- Gal basilar arteries. However, in basilar arteries transduced with AdCMVeNOS even when the endothelium was removed, stimulation with bradykinin (3 x 10- 11 to 10-9 mol/L) caused relaxations as well as increases in cGMP production. The relaxations to bradykinin were completely blocked by an NOS inhibitor, N(G)-nitro-L-arginine methyl ester. Electron microscopic analysis revealed that recombinant eNOS protein was expressed in fibroblasts of the basilar artery adventitia. These results suggest that genetically modified adventitial fibroblasts may restore production of NO in cerebral arteries without endothelium. Our findings support a novel concept in vascular biology that fibroblasts in the adventitia may play a role in the regulation of vascular tone after successful transfer and expression of recombinant eNOS gene.",
keywords = "Adenoviral vector, Bradykinin, Fibroblasts, Gene therapy, Gene transfer",
author = "Masato Tsutsui and Chen, {Alex F Y} and Timothy O'Brien and Crotty, {Thomas B.} and Katusic, {Zvonimir S}",
year = "1998",
language = "English (US)",
volume = "18",
pages = "1231--1241",
journal = "Arteriosclerosis, Thrombosis, and Vascular Biology",
issn = "1079-5642",
publisher = "Lippincott Williams and Wilkins",
number = "8",

}

TY - JOUR

T1 - Adventitial expression of recombinant eNOS gene restores NO production in arteries without endothelium

AU - Tsutsui, Masato

AU - Chen, Alex F Y

AU - O'Brien, Timothy

AU - Crotty, Thomas B.

AU - Katusic, Zvonimir S

PY - 1998

Y1 - 1998

N2 - The current study was designed to determine the effect of recombinant endothelial nitric oxide synthase (eNOS) gene expression on endothelium- dependent relaxations to bradykinin in isolated canine basilar, coronary, or femoral arteries. Arterial rings were exposed ex vivo (30 minutes at 37°C) to an adenoviral vector encoding either the eNOS gene (AdCMVeNOS) or the β- galactosidase reporter gene (AdCMVβ-Gal). Twenty-four hours after transduction, transgene expression was evident mainly in the adventitia. Expression of recombinant proteins was much higher in basilar arteries than in coronary or femoral arteries. Rings of control, AdCMVβ-Gal, and AdCMVeNOS arteries with and without endothelium were suspended for isometric tension recording. Levels of cGMP were measured by radioimmunoassay. In AdCMVeNOS basilar arteries with endothelium, relaxations to low concentrations of bradykinin (3 x 10-11 to 10-9 mol/L) were significantly augmented. In contrast, in coronary and femoral arteries with endothelium, AdCMVeNOS transduction did not affect relaxations to bradykinin. Removal of the endothelium abolished bradykinin-induced relaxations in control and AdCMVβ- Gal basilar arteries. However, in basilar arteries transduced with AdCMVeNOS even when the endothelium was removed, stimulation with bradykinin (3 x 10- 11 to 10-9 mol/L) caused relaxations as well as increases in cGMP production. The relaxations to bradykinin were completely blocked by an NOS inhibitor, N(G)-nitro-L-arginine methyl ester. Electron microscopic analysis revealed that recombinant eNOS protein was expressed in fibroblasts of the basilar artery adventitia. These results suggest that genetically modified adventitial fibroblasts may restore production of NO in cerebral arteries without endothelium. Our findings support a novel concept in vascular biology that fibroblasts in the adventitia may play a role in the regulation of vascular tone after successful transfer and expression of recombinant eNOS gene.

AB - The current study was designed to determine the effect of recombinant endothelial nitric oxide synthase (eNOS) gene expression on endothelium- dependent relaxations to bradykinin in isolated canine basilar, coronary, or femoral arteries. Arterial rings were exposed ex vivo (30 minutes at 37°C) to an adenoviral vector encoding either the eNOS gene (AdCMVeNOS) or the β- galactosidase reporter gene (AdCMVβ-Gal). Twenty-four hours after transduction, transgene expression was evident mainly in the adventitia. Expression of recombinant proteins was much higher in basilar arteries than in coronary or femoral arteries. Rings of control, AdCMVβ-Gal, and AdCMVeNOS arteries with and without endothelium were suspended for isometric tension recording. Levels of cGMP were measured by radioimmunoassay. In AdCMVeNOS basilar arteries with endothelium, relaxations to low concentrations of bradykinin (3 x 10-11 to 10-9 mol/L) were significantly augmented. In contrast, in coronary and femoral arteries with endothelium, AdCMVeNOS transduction did not affect relaxations to bradykinin. Removal of the endothelium abolished bradykinin-induced relaxations in control and AdCMVβ- Gal basilar arteries. However, in basilar arteries transduced with AdCMVeNOS even when the endothelium was removed, stimulation with bradykinin (3 x 10- 11 to 10-9 mol/L) caused relaxations as well as increases in cGMP production. The relaxations to bradykinin were completely blocked by an NOS inhibitor, N(G)-nitro-L-arginine methyl ester. Electron microscopic analysis revealed that recombinant eNOS protein was expressed in fibroblasts of the basilar artery adventitia. These results suggest that genetically modified adventitial fibroblasts may restore production of NO in cerebral arteries without endothelium. Our findings support a novel concept in vascular biology that fibroblasts in the adventitia may play a role in the regulation of vascular tone after successful transfer and expression of recombinant eNOS gene.

KW - Adenoviral vector

KW - Bradykinin

KW - Fibroblasts

KW - Gene therapy

KW - Gene transfer

UR - http://www.scopus.com/inward/record.url?scp=0031866890&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031866890&partnerID=8YFLogxK

M3 - Article

C2 - 9714129

AN - SCOPUS:0031866890

VL - 18

SP - 1231

EP - 1241

JO - Arteriosclerosis, Thrombosis, and Vascular Biology

JF - Arteriosclerosis, Thrombosis, and Vascular Biology

SN - 1079-5642

IS - 8

ER -